Share Name Share Symbol Market Type Share ISIN Share Description
Synergy Hlth. LSE:SYR London Ordinary Share GB0030757263 ORD 0.625P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 2,325.00p 0.00p 0.00p - - - 0 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 408.8 43.6 56.9 40.9 1,395.06

Synergy Health (SYR) Latest News

More Synergy Health News
Synergy Health Takeover Rumours

Synergy Health (SYR) Share Charts

1 Year Synergy Health Chart

1 Year Synergy Health Chart

1 Month Synergy Health Chart

1 Month Synergy Health Chart

Intraday Synergy Health Chart

Intraday Synergy Health Chart

Synergy Health (SYR) Discussions and Chat

Synergy Health Forums and Chat

Date Time Title Posts
03/11/201522:17Synergy...a clean up act in the NHS194
24/4/200820:58Synergy Healthcare going whoooossshhhhh54
11/5/200617:11Sidney Resources: Mexican small cap Miner26
30/6/200321:00Syria Next?6
19/3/200311:40Oi...premium board users...share a little on SYR !!!86

Add a New Thread

Synergy Health (SYR) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Synergy Health trades in real-time

Synergy Health (SYR) Top Chat Posts

DateSubject
29/9/2016
09:20
Synergy Health Daily Update: Synergy Hlth. is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker SYR. The last closing price for Synergy Health was 2,325p.
Synergy Hlth. has a 4 week average price of - and a 12 week average price of -.
The 1 year high share price is - while the 1 year low share price is currently -.
There are currently 60,002,784 shares in issue and the average daily traded volume is 0 shares. The market capitalisation of Synergy Hlth. is £1,395,064,728.
08/2/2013
19:12
analyst: Investors Chronicle says Sell Shares in cleaning and sterilisation specialist Synergy Health (SYR) have been notably strong performers lately, outpacing shares in similar companies by 20 per cent over the past quarter on the back of some promising deals in new markets. True, Synergy almost certainly has a solid future in its key markets, but, in the medium-term, the share rating has moved too far ahead of the group's growth prospects. Really brave punters might try 'short selling' the stock; meanwhile, shareholders might simply opt to sell. The trigger for the big share-price move was Synergy's decisive entry into the US hospitals market. The acquisition of SRI/Surgical Express, in particular, for $25m (£17m) got the City's admiration, especially because the price paid looked good for a business generating sales of more than $100m. However, it is not clear what effect the expansion will have on Synergy's underlying profit margins. These were more than 15 per cent in the first half of 2012-13, but there is a risk that the peculiarities of the US business could eat into them. This is because most US hospitals, unlike those in Synergy's core business with the NHS, have their own sterilising and cleansing facilities on-site. That means Synergy would be paid a fee as a service provider, rather than as a more lucrative full-facility operator. There is no doubt that the US market is far larger than anything Synergy has entered so far and the opportunities are there. However, the question hanging over the States-side project is whether investors have taken into account the amount of investment needed over the next few years to bring the service up to Synergy's standards. That could generate big one-off costs that may not be adequately priced in. As support services businesses go, Synergy is unusual because a lot of its capital is tied up in tangible assets. That's because often it has to fund and build hospital cleaning facilities itself for the contracts it wins. That means lots of upfront spending in order to grow sales, as each new contract can mean another round of construction. Analysts at broker CanaccordGenuity estimate that to achieve an adequate cashflow return on its capital of around 8 per cent, the company must invest between £15m and £30m annually to generate the required income. This inhibits shareholders' returns as the lead time between winning a contract and starting operations is between 18 months to two years. CanaccordGenuity estimates that the company will clock up capital spending of £75m over the next three years. Given the lag between spending and revenue-generation, sales growth will be deferred, making Synergy much more cyclical than is generally perceived. Synergy also has its share of immediate problems resulting from austerity in the European Union. This affects its Dutch business supplying hospital linen, in particular. Meanwhile, a spending squeeze in the NHS, while not affecting existing contracts due to the importance for patient care, could slow the pipeline of new work that Synergy could bid for. Share tip summary Trading on almost 17 times forecast underlying earnings, Synergy's shares are rated just above the UK average for the healthcare services sector at a time when significant parts of its operations face slowing growth in its established markets. Granted, expansion into the US seems like a good move given the size of the market, and European austerity will not last for ever. Yet the rating has moved to a level that is vulnerable to correction if the company fails to outperform the market's expectations. Given the consistently high capital spending Synergy must undertake, the possibility of disappointment is higher than average. Sell.
16/11/2010
14:38
milacs: Good looking chart and no followers. Will the share price push through the 800p barrier this time. M
20/11/2007
09:00
assegai: Interims out to day are very positive. Key points are: Revenue up 52% to £102 million. Operating profit up 115% to £15.3 million. Profit after taxation up 93% to £8.5 million. Strong statement expecting good year end results. The share price now is relatively low so well worth taking a detailed look at.
25/8/2001
19:01
6million dollarman: THE WEEKLY BB REVIEW - GREYSTONE As Synergy Healthcare - Keep Yer eye's on this one Trading Starts August 20th (SYR) shows, it was an inauspicious start for the newcomer. 6million dollarman was fan numero uno and looking at a long-term investment rather than a quick shot in the bionic arm. Dil was persudaded by the silver tongue of stustu that it was an interesting sector and northwards showed some interest too, but otherwise this one seemed to pass by the PBB without much comment. A good end to the week pushed the share price back to the issue price. It will be interesting to see how it fares in the lead up to the interim results which are due soon. Certainly worth adding to my Monitor in the short-term. Should have kept mi mouth shut $%-)) Thanks Greystone 6M$M
Synergy Health share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20160930 01:33:35